In order to enhance the attention of medicine field on TCP (Thrombocytopenia), to promote research development of TCP and to elevate the scientific research level of medical workers of middle-young age at home on TCP, thereby strengthening the clinical management of TCP and the benefit for patients, 3SBio invested and established Sunshine TCP Scientific Research Fund for Youth and Middle-aged in August 2015 which is administrated by Shenyang Pharmaceutical University.

The fund aims to promote doctors of middle-young age at home actively to carry out the relevant basic and clinical research work on TCP (Thrombocytopenia). Its funding activities include TCP basic research, TCP clinical research, rational drug use and pharmacoeconomics research on TCP;and funding target is clinician and scientific and technical worker of middle-young age (no older than 45 years) occupied in the above-mentioned scientific research activities.